Skip to main content
Psyched Wellness Ltd. logo

Psyched Wellness Ltd. — Investor Relations & Filings

Ticker · PSYC ISIN · CA74447P1009 LEI · 98450042FD0B96F3EL64 CSE Manufacturing
Open in API
Filings indexed 472 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country CA Canada
Listing CSE PSYC

About Psyched Wellness Ltd.

https://psyched-wellness.com

Psyched Wellness Ltd. is a life sciences company focused on the research, development, and distribution of innovative health supplements derived from the Amanita Muscaria mushroom. The company utilizes a proprietary natural decarboxylation process to convert the mushroom's ibotenic acid into Muscimol, a compound known for its sedative and relaxing properties, while ensuring the removal of dangerous toxins. Its flagship product, "Calm," is a micro-serving tincture marketed as a bedtime ritual to promote relaxation, body comfort, and improved sleep quality. Psyched Wellness emphasizes product safety and predictability, supported by extensive preclinical trials and third-party lab testing, positioning itself as a provider of ethically sourced, mushroom-derived consumer packaged goods.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2026-04-28 English
Interim MD&A - English.pdf
Regulatory Filings
2026-04-28 English
Interim financial statements/report – English.pdf
Regulatory Filings
2026-04-28 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release highlighting recent U.S. federal policy developments supporting the psychedelic sector and the company's positioning in this context. It contains no financial statements, no detailed financial data, no regulatory filings, no voting results, no management or board changes, no audit information, and no earnings data. It is a general corporate announcement about policy momentum and company strategy commentary. The document length is about 5,051 characters, which is relatively short and reads like a news or regulatory announcement rather than a detailed report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit any other specific category.
2026-04-23 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 85% confidence The document is a Canadian regulatory compliance form (Form 45-106F1 Report of Exempt Distribution) filed on SEDAR+ detailing securities distributed under prospectus exemptions. It is neither an earnings release, annual report, nor a capital/financing update in the usual sense but a statutory distribution report. This fits the fallback category for miscellaneous regulatory filings that do not fit other specific categories.
2026-03-31 English
Other.pdf
Regulatory Filings Classification · 82% confidence The text is not an earnings release, management report, or annual/interim financial report. It is a detailed legal agreement governing a private placement (financing), including subscription, tranche closings, and investor board nomination rights. This type of contract is not a standard shareholder meeting material (AGM), not a dividend or interest‐rate notice, and not a proxy or remuneration filing. It most closely fits into the broad “Regulatory Filings” fallback category, as it does not match any other more specific category in our taxonomy.
2026-03-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.